All Articles on Vaccine
Clinical trial will evaluate mpox vaccine for adolescentsThe NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
Top research highlights in 2022From cardiovascular health to cancer screening, these are the research stories that made headlines over the last year.
Overcoming undervaccinationClarissa Hsu, PhD, asked parents why they decline or delay vaccinating their children.
Researchers begin trial for mRNA flu vaccineThe investigational vaccine is in the third phase of trials and targets flu strains expected to circulate this winter.
New study confirms safety of shingles vaccineKPWHRI researchers analyzed data from more than 640,000 vaccine doses to understand risk of severe reactions.
KPWHRI begins new phase of flu surveillanceKPWHRI receives $10 million to continue vaccine effectiveness research for flu, COVID-19, and other respiratory diseases
Gene-edited malaria vaccine warrants further studyEncouraging immune-response and safety data emerge from preliminary human test of genetically attenuated parasite vaccine.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.